Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline – Business Wire
Gilead Sciences and Lakefront Complete buyout of Ouro Medicines to Further Expand Inflammation Pipeline Business Wire Source: news.google.com